相关实验视频

Updated: Jul 12, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

子中的l-Dgr9-trans-Tetrahydrocannabinol:对行为影响的耐受性

D E McMillan, L S Harris, J M Frankenheim

    Science (New York, N.Y.)
    |July 31, 1970
    PubMed
    概括

    德尔塔-9-四大麻 (THC) 在子中表现出快速耐受性发展,最初阻断反应的剂量在一周内变得无效. 长期服用更高剂量并没有扰乱行为,也没有观察到戒断症状.

    更多相关视频

    Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

    Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

    Published on: February 28, 2025

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates06:09

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

    Published on: May 30, 2025

    相关概念视频

    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

    Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

    Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
    Two synthetic agonists of THC,...